Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
97,996,626
-
Number of holders
-
46
-
Total 13F shares, excl. options
-
20,554,611
-
Shares change
-
+1,516,360
-
Total reported value, excl. options
-
$153,544,033
-
Value change
-
+$11,326,984
-
Put/Call ratio
-
1.02%
-
Number of buys
-
15
-
Number of sells
-
-1
-
Price
-
$7.47
Significant Holders of aTYR PHARMA INC - COMMON STOCK (ATYR) as of Q4 2021
53 filings reported holding ATYR - aTYR PHARMA INC - COMMON STOCK as of Q4 2021.
aTYR PHARMA INC - COMMON STOCK (ATYR) has 46 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 20,554,611 shares
of 97,996,626 outstanding shares and own 20.97% of the company stock.
Largest 10 shareholders include FEDERATED HERMES, INC. (5,222,250 shares), FMR LLC (4,168,601 shares), VR Adviser, LLC (1,565,000 shares), Tikvah Management LLC (1,225,833 shares), TANG CAPITAL MANAGEMENT LLC (1,113,453 shares), VANGUARD GROUP INC (1,113,191 shares), Deep Track Capital, LP (1,100,000 shares), Alyeska Investment Group, L.P. (674,975 shares), BAKER BROS. ADVISORS LP (625,000 shares), and Stonepine Capital Management, LLC (525,531 shares).
This table shows the top 46 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.